Lifeline Drugs & Pharma (Delisted) share price

BSE: 506113Retailing

Lifeline Drugs & Pharma Ltd · Face value ₹1 · Listed Jun 1983

Last traded ₹134.40 on 27 Aug 2015

Delisted on 23 Nov 2023.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.

Share price history

Daily closes since Nov 2013, adjusted for splits and bonuses. Earlier closes are left out: on 14 Nov 2013 the price changed in a way no corporate action on record explains.

Daily close, ₹ per share

Results for the quarter to Mar 2018

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

Revenue
₹3.40 Cr+14.1% on a year ago · +1,628.3% on the quarter before
Operating profit
−₹0.83 Cr
Net profit
−₹0.50 Cr
Operating margin
−24.3%
Net margin
−14.6%

From revenue to net profit, ₹ crore

  1. Revenue3.4
  2. Materials and goods−4.2
  3. Employee costs0.0
  4. Other expenses0.0
  5. Operating profit−0.8
  6. Depreciation0.0
  7. Other income+0.3
  8. Finance costs0.0
  9. Profit before tax−0.5
  10. Tax0.0
  11. Net profit−0.5

Lifeline Drugs & Pharma results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Mar 2018. Results for the quarter to Jun 2018 were due by 14 Aug 2018, 45 days after it ends. Every company's dates are on the results calendar.

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss
2.40.4Jun 151.90.2Sep 152.0−0.1Dec 15Mar 160.50.2Jun 160.3Sep 160.3Dec 163.0−0.8Mar 170.40.2Jun 170.20.1Sep 170.20.2Dec 173.4−0.5Mar 18
Peak revenue ₹3.40 Cr, quarter to Mar 2018; lowest ₹0.19 Cr, quarter to Sep 2017A loss in the quarter to Mar 2018, −₹0.50 Cr

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
77.9%−49.7%−1.9%−49.7%−33.1%−24.3%17.6%13.0%−3.7%44.0%−25.6%61.7%64.2%77.9%−14.6%Jun 15Dec 15Jun 16Dec 16Jun 17Dec 17Mar 18
₹ croreJun 2013Sep 2013Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Q1Sep 2017Dec 2017Q3Mar 2018
Revenue from operations9.63.39.617.613.811.29.38.82.41.92.0–0.5––3.00.40.20.23.4
––––––––––––––––0.40.30.34.2
Materials and goods bought9.43.29.417.513.711.28.79.52.31.92.4–0.5––4.00.30.30.34.2
Employee costs––––––––––––––––0.00.00.00.0
Other expenses––––––––––––––––0.00.00.00.0
Operating profit before depreciation––––––––––––––––0.0−0.1−0.1−0.8
Operating margin––––––––––––––––−1.9%−49.7%−33.1%−24.3%
Depreciation and amortisation–––0.00.00.00.00.00.00.00.0––––0.00.00.00.00.0
Other income–0.10.20.40.40.4–0.30.30.30.3–0.30.30.30.30.20.20.20.3
Finance costs––––––––––––––––0.00.00.00.0
One-off items––––––––––––––––0.00.00.00.0
Profit before tax0.10.10.40.40.50.50.5−0.60.40.2−0.1–0.20.30.3−0.80.20.10.2−0.5
–––0.3–––––––––––0.00.00.00.00.0
Tax rate–––83.2%––––––––––––0.0%0.0%0.0%–
Net profit0.10.10.40.10.50.50.5−0.60.40.2−0.1–0.20.30.3−0.80.20.10.2−0.5
Net margin1.1%3.6%3.9%0.4%4.0%4.1%5.1%−6.5%17.6%13.0%−3.7%–44.0%––−25.6%61.7%64.2%77.9%−14.6%
Earnings per share–––––––−₹0.16–––––––−₹0.21₹0.06₹0.03₹0.04–
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarter to Mar 2016.

Segment results by quarter

Standalone, ₹ crore, quarters to Mar 2018.

  • Finance and Investment activities

    Revenue, ₹ crore
    Profit, ₹ crore
  • Textile Activities

    Revenue, ₹ crore
    Profit, ₹ crore
  • Steel Activities

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreJun 2017Sep 2017Dec 2017Mar 2018
Revenue of all businesses0.40.20.23.4
Company revenue, as in its results0.40.20.23.4
Revenue0.1––3.4
Profit0.3––−0.5
Margin391.5%––−14.6%
Assets23.5–––
Revenue0.30.00.00.0
Revenue0.00.00.00.0
Revenue––0.2–
Revenue–0.2––
–––0.0
0.00.00.0–
Profit is before tax and finance costs, the way companies report their segments.

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
620.4Mar 09620.3Mar 10Mar 110.1Mar 120.1Mar 13400.7Mar 14430.6Mar 15Mar 163.50.0Mar 174.10.00Mar 18
Peak revenue ₹62 Cr, year to Mar 2010; lowest ₹3.48 Cr, year to Mar 2017

Operating and net margin, per cent

  • Operating margin
  • Net margin
1.6%−24.0%−24.0%0.6%0.4%1.6%1.5%0.1%0.0%Mar 09Mar 11Mar 13Mar 15Mar 17Mar 18

Results for the year to Mar 2018

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue4.1
  2. Materials and goods−5.1
  3. Employee costs0.0
  4. Other expenses0.0
  5. Operating profit−1.0
  6. Depreciation0.0
  7. Other income+1.0
  8. One-off items0.0
  9. Finance costs0.0
  10. Profit before tax0.0
  11. Tax0.0
  12. Net profit0.0

What the company owns

  • Plant, investments and other assets₹13,63,526 Cr
  • Inventory₹9,14,326 Cr
  • Cash and bank₹27,482 Cr
  • Receivables₹4,667 Cr

What pays for it: net worth and liabilities

  • Net worth₹21,59,497 Cr
  • Owed to suppliers₹1,50,350 Cr
  • Other liabilities₹154 Cr

Lifeline Drugs & Pharma business segments, year to Mar 2018

A reportable segment is a line of business the company must report on its own. Standalone, ₹ crore, as the company reports them. A segment at a loss has no share of profit.

Revenue by segment

₹5.14 CrTotal
  • Finance and Investment activities₹4.86 Cr94.5% of total
  • Textile Activities₹0.26 Cr5.0% of total
  • Steel Activities₹0.02 Cr0.5% of total

Profit by segment

  • Finance and Investment activities₹0.05 Cr69.4% of total
  • Steel Activities₹0.02 Cr30.6% of total

Segment results by year

Standalone, ₹ crore, years to March.

  • Finance and Investment activities

    Revenue, ₹ crore
    Profit, ₹ crore
  • Textile Activities

    Revenue, ₹ crore
    Profit, ₹ crore
  • Steel Activities

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2018
Revenue of all businesses5.14
Company revenue, as in its results4.15
Revenue4.86
Profit0.05
Margin1.1%
Revenue0.26
Revenue0.02
0.00
Profit is before tax and finance costs, the way companies report their segments.

Profit and loss

Standalone, ₹ crore, years to March. No results on record for the years to Mar 2011 and Mar 2016.

₹ croreMar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue from operations62.162.2–––40.142.7–3.54.1
–––––––––5.1
Materials and goods bought61.361.7–––39.643.1–4.55.1
Employee costs–––––––––0.0
Other expenses–––––––––0.0
Operating profit before depreciation–––––––––−1.0
Operating margin–––––––––−24.0%
Materials, % of revenue–––––––––122.7%
Employee costs, % of revenue–––––––––0.6%
Other expenses, % of revenue–––––––––0.6%
Depreciation and amortisation–––––0.00.0–0.00.0
Operating profit after depreciation–––––––––−1.0
Other income–––0.10.30.81.6–1.11.0
Finance costs0.00.0–––––––0.0
One-off items–––––––––0.0
Profit before tax0.50.4–0.10.21.00.9–0.00.0
0.20.1––0.10.30.3–0.00.0
Net profit0.40.3–0.10.10.70.6–0.00.0
Net margin0.6%0.4%–––1.6%1.5%–0.1%0.0%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2009 and Mar 2010: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2012 and Mar 2013: the statement does not state its revenue, finance costs or depreciation, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2014, Mar 2015 and Mar 2017: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2018
21,59,497
Share capital3,62,400
Reserves17,97,097
Borrowings0
1,50,504
Liabilities due after a year0
Total assets23,10,001
9,298
23,00,703
Net debt−27,482
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2009, Mar 2010, Mar 2012, Mar 2013, Mar 2014, Mar 2015 and Mar 2017, so its lines and the ratios worked from it are blank there.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
–––₹0.17–₹0.00₹0.00
As stated that year₹2.12₹0.46–₹0.17–₹0.00₹0.00
–––₹0.17–₹0.00₹0.00
Market cap at the year end (₹ crore)111–714–––
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from.

Ratios

Standalone, years to March.

RatioMar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue growth23.4%0.3%––––6.5%––19.1%
Net profit growth25.7%−24.4%––176.5%364.5%−4.7%––−84.0%
Earnings per share growth–––––––––0.0%
Return on equity–––––––––0.0%
Return on capital employed–––––––––0.0%
Debt to equity–––––––––0.00
Receivable days–––––––––4,10,856
Inventory days–––––––––6,55,78,510
Payable days–––––––––1,07,83,618
Cash conversion cycle, days–––––––––5,52,05,747
Working capital days–––––––––18,68,58,942
Asset turnover–––––––––0.00
Assets per rupee of net worth–––––––––1.07
Sales per rupee of plant–––––––––0.01
Plant being built, % of plant in use–––––––––0.0%
Interest cover is left blank for the year to Mar 2018: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2009, Mar 2010, Mar 2012, Mar 2013, Mar 2014, Mar 2015 and Mar 2017, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2018.

Return on assets, latest year
0.0%
Measure10 years5 years3 years
Revenue growth, yearly rate−22.1%–−54.0%
Profit growth, yearly rate−44.3%−64.5%−89.1%
Net margin, average–0.8%0.1%

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Altman Z-scorePublished threshold 1.1–––––––––23.71
Effective tax ratePublished threshold 17.16 per cent33.2133.50––30.8832.9231.13–−25.0011.11
A threshold marked as ours has no published figure; it is the line we read the check against.

Lifeline Drugs & Pharma share price by year

Each calendar year to 2015.

YearClose at year endChangeHighest closeLowest close
2015134.40−46.7%264.90134.40
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2015 close is its last trade, on 27 Aug 2015.

Recent sessions

The 10 trading days to 27 Aug 2015, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
27 Aug 2015134.40134.40134.40134.40134.401,774
26 Aug 2015168.00247.90167.90167.90168.057,691
25 Aug 2015167.30230.00167.30209.80209.8917,628
24 Aug 2015213.00229.80206.00206.00210.119,057
21 Aug 2015225.10240.00222.90231.00231.4916,449
20 Aug 2015227.00230.00227.00230.00227.004,201
19 Aug 2015231.00231.00230.00230.00230.00200
18 Aug 2015216.00233.00216.00229.50225.7127,591
17 Aug 2015212.10219.90212.00216.80215.595,714
14 Aug 2015201.00220.00201.00216.00213.4839,126
Prices in ₹ per share as traded, not adjusted.

Price adjustments

What the price chart is corrected for, so it reads as one share held throughout.

Ex-dateEventPrice factorWhat happened
14 Nov 2013Price move–Between two trading sessions the price fell 47% or more, or rose 90% or more. The company made an announcement in time for trading that day or the trading day before. Earlier prices are not shown.
10 Jan 2013Price move–Between two trading sessions the price fell 47% or more, or rose 90% or more. No corporate action is on record. Earlier prices are not shown.
Where an event has no factor that can be worked out, the chart leaves out the closes before it.

Company details

BSE code
506113
ISIN
INE776N01028
Industry
Retailing
CIN
L51909MH1982PLC028972
Corporate identity number, the registrar of companies' code for it
Incorporated
1982
Registered office
204, B-Wing, New Prabhat SRA CHS Ltd., Chikuwadi, W.E.Highway, Andheri (E), Mumbai 400099, Maharashtra
Share registrar
Purva Sharegistry (India) Pvt. Ltd
Keeps the register of shareholders and handles transfers and dividend payments